Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRAVO 2/3 bivalirudin versus unfractionated heparin in TAVR
NL-OMON39580Phase 3Active, not recruiting
- Sponsor
- The Medicines Company
- Start
- Dec 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in aortic stenosis (AS) comparing Bivalirudin with Unfractionated heparin (2 arms). Started Dec 2012; status: active, not recruiting.
02
Drugs
bivalirudinheparin
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on NL-OMON39580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39580.